IL22 and inflammatory bowel disease: A study on patients with inflammatory bowel disease found that SCFAs, metabolites of gut microbiota, in particular propionate, regulate IL-17 and IL-22 production by human intestinal γδ T lymphocytes by inhibiting HDAC activity [45].